SARS-CoV-2 Infection in a Patient on Chronic Hydroxychloroquine Therapy: Implications for Prophylaxis

Authors

Khalid M. Dousa, Case Western Reserve UniversityFollow
Sharad S. Malavade, Case Western Reserve University
Jennifer Furin, Case Western Reserve UniversityFollow
Barbara Gripshover, Case Western Reserve UniversityFollow
Marjorie Hatszegi, Case Western Reserve University
Leila Hojat, Case Western Reserve UniversityFollow
Elie Saade, Case Western Reserve UniversityFollow
Robert A. Salata, Case Western Reserve University

Document Type

Article

Publication Date

4-27-2020

Abstract

People exposed to COVID-19 have a risk of developing disease, and health care workers are at risk at a time when they are badly needed during a health care crisis. Hydroxychloroquine and chloroquine have been used as treatment and are being considered as prophylaxis. Our patient developed COVID-19 while on hydroxychloroquine and although more work is needed, this calls into question the role of these medications as preventive therapy.

Keywords

SARS-CoV-2, COVID19, hydroxychloroquine, pandemic

Publication Title

IDCases

Rights

© 2020 The Author(s). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.

Recommended Citation

Dousa, K. M., Malavade, S. S., Furin, J., Gripshover, B., Hatszegi, M., Hojat, L., … Salata, R. A. (2020). Sars-Cov-2 Infection in a Patient on Chronic Hydroxychloroquine Therapy: Implications for Prophylaxis. IDCases. https://doi.org/10.1016/j.idcr.2020.e00778